M. Cazzola (Naples, Italy), K. F. Rabe (Leiden, The Netherlands)
Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma
Y. To, I. M. Adcock, P. J. Barnes, K. Ito (London, United Kingdom)
|   |
The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma
N. L. Shaporova, V. I. Trofimov, O. V. Dudina, I. A. Fedoseeva, D. P. Lebedeva (St. Petersburg, Russian Federation)
| |
Theophylline inhibits mobilization of eosinophil induced by interleukin-5 (IL-5) from femoral bone marrow into the blood
T. Otani, K. Yamana, M. Kato (Saitama, Kishiwada, Japan)
| |
Inhibitors of PDE4 delay eosinophil apoptosis
J. Parkkonen, E. Moilanen, H. Kankaanranta (Tampere, Finland)
| |
Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma
R. W. Dal Negro, S. Tognella, C. Micheletto, F. Trevisan (Bussolengo, Italy)
| |
Efficacy of specific allergy vaccination in house dust mite asthma
G. Blumberga, L. Groes, L. Haugaard, R. Dahl (Aarhus, Horsholm, Denmark)
| |
Bronchial asthma as neurogenic paroxysmal inflammatory disease - high efficacy of antiepileptic drug oxcarbazepine in asthma monotherapy
M. Lomia, M. Pruidze, Z. Chapichadze (Tbilisi, Georgia)
| |
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
F. Blasi, R. B. Nieman, P. N. Black, S. L. Johnston (Milan, Italy; Bridgewater, United States Of America; Auckland, New Zealand; London, United Kingdom)
| |